Publication | Closed Access

β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer

Breast OncologyHormonal ReceptorImmunologyTumor ImmunityPathologyβ2-Adrenergic Receptor ExpressionBreast CancerPoor PrognosisEndocrinologyMedicineTumor BiologyEndocrine-related Cancer